Curtis, Jeffrey R.
Strand, Vibeke http://orcid.org/0000-0003-4978-4072
Golombek, Steven J.
Karpouzas, George A.
Zhang, Lixia
Wong, Angus
Patel, Krishna
Dines, Jennifer
Akmaev, Viatcheslav R. http://orcid.org/0000-0001-8361-7708
Article History
Received: 15 September 2023
Accepted: 17 October 2023
First Online: 10 November 2023
Declarations
:
: Jeffrey Curtis reported financial relationships with AbbVie Pharmaceuticals, Amgen Inc., Bendcare, Bristol Myer Squib Company, CorEvitas, Eli Lilly & Company, Janssen Pharmaceuticals, Myriad Genetics, Novartis, Pfizer Inc., Regeneron Pharmaceuticals Inc., Roche, Scipher Medicine Corp., and UCB. Vibeke Strand reported consulting fees from Abbvie Pharmaceuticals, Alpine Immune Sciences, Alumis, Amgen Inc., Aria Pharmaceuticals, AstraZeneca, Atom Biosciences, Bayer AG, Bioventus Inc., Blackrock Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim, Celltrion Inc., Citryll, Equillium, Ermium, Fortress Biotech, Genentech/Roche Inc., Gilead Sciences Inc., GlaxoSmithKline Pharmaceuticals Ltd, Horizon Therapeutics, Inmedix Inc., Janssen Pharmaceuticals, Kiniksa Pharmaceuticals, Lilly, Merck & Co., MiMedx Group, Novartis Pharmaceuticals Corporation, Omeros, Pfizer Inc., R-Pharm, RAPT, Regeneron Pharmaceuticals Inc., Samsung, Sandoz, Sanofi, Scipher Medicine Corp., Setpoint Medical, SOFUSA, Spherix Global Insights, and Urica. George Karpouzas reported financial support from Pfizer and is a clinical trial adjudicator for Janssen. Steven Golombek reported speaking honoraria from Amgen Inc. and AstraZeneca. Lixia Zhang, Angus Wong, Jennifer Dines, Krishna Patel, and Viatcheslav Akmaev reported financial support provided by Scipher Medicine Corp.
: AIMS is a prospective, longitudinal, multi-institutional clinical database of patients with RA managed by providers in clinical practice. A total of 72 US private and academic rheumatology practices participate in AIMS under Institutional Review Board (Advarra IRB Services, Columbia, MD, USA; IRB #PRO00044807) approval, with informed consent obtained from all enrolled patients. All patient data is deidentified, and management of clinical data is conducted in accordance with the Health Insurance Portability and Accountability Act (HIPAA) [CitationRef removed].